SecBot SecBot
144 ·Filed Aug 13, 2026

DYN

Dyne Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago SEC0001972481-26-000258
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine, small insider sale by a director for tax-related equity compensation purposes. No material read-through for the stock. Monitor for any larger insider sales or changes in ownership patterns, but this filing alone does not warrant a trading response.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$25.70
T+0 close · Aug 13, 2026 · via day close
Latest settled
−26.96%
T+60 · $18.77
Vs SPY
−24.16%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 14 $25.70entry
  2. T+1 · 3mo ago +1.75%α +2.22% · $26.15
  3. T+5 · 3mo ago +1.56%α +2.92% · $26.10
  4. T+20 · 2mo ago −27.94%α −25.95% · $18.52
  5. T+60 · 8d ago −26.96%α −24.16% · $18.77
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Douglas Kerr filed a Form 144 notice of intent to sell 2,443 shares of Dyne Therapeutics common stock, with an estimated aggregate market value of approximately $64,203 based on the filing date. The shares were acquired through vesting of restricted stock units granted under the issuer's equity compensation plan. This is a routine, small-dollar sale relative to the company's $4.9B market cap and does not signal a change in business outlook or management confidence.

Key Facts

  • Director Douglas Kerr filed Form 144 to sell 2,443 shares of Dyne Therapeutics common stock.
  • Estimated aggregate market value of the proposed sale is approximately $64,203.
  • Shares were acquired through vesting of restricted stock units (RSUs) granted under equity compensation plans on 08/12/2026 and 06/05/2026.
  • The sale is to be executed through Stifel Nicolaus & Company Inc.
  • The filing date is August 13, 2026; the proposed sale is for the open market on Nasdaq.

Financial Impact

Proposed sale of 2,443 shares valued at approximately $64,203, less than 0.001% of the company's $4.9B market cap.

dilution

Risk Factors

  • Insider selling could increase if additional directors or officers file Form 144s in coming weeks.
  • The sale is not yet executed; the insider may choose not to sell.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001972481-26-000258
Document: 0001972481-26-000258-index.html0001972481-26-000258
Document: 0001972481-26-000258.txt0001972481-26-000258

Track record

54 reports on DYN

Performance horizon

12 of 16 bullish or bearish reports moved the stock their way by T+20. Best: +46.36% at T+60 after the May 20, 2026 report. 15 of 16 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $16.77 Now $16.70 −0.39% settles Dec 15
  2. Nov 13, 20263d ago 144 Neutral 2/10 Entry $17.16 Now $16.70 −2.68% settles Dec 15
  3. Nov 13, 20263d ago 144 Neutral 2/10 Entry $17.16 Now $16.70 −2.68% settles Dec 15
  4. Nov 5, 202611d ago 8-K Neutral 5/10 No price data
  5. Nov 5, 202611d ago Press Release Neutral 5/10 Entry $17.36 Now $16.70 −3.80% settles Dec 4
  6. Oct 29, 202618d ago Institutional Cluster Neutral 2/10 Entry $17.04 Now $16.70 −2.00% settles Nov 27
  7. Oct 22, 202625d ago Press Release Neutral 2/10 Entry $15.62 Now $16.70 +6.91% settles Nov 20
  8. Oct 12, 20265w ago Institutional Cluster Mixed 4/10 Entry $15.96 to $18.62 Now $16.70 +4.64% ▲ +16.67% +19.93% vs SPY
  9. Sep 29, 20266w ago Press Release Bullish 7/10 Entry $16.11 to $16.94 Now $16.70 +3.66% ▲ +5.15% +4.23% vs SPY
  10. Sep 8, 20269w ago Insider Cluster Neutral 3/10 Entry $19.19 to $15.97 Now $16.70 −12.98% ▼ −16.78% −18.72% vs SPY
Showing 10 of 54

US Market Status

Market Closed · Opens Wed (11h 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 13, 2026